Finance

Lists
BLRX:NASDAQ
BioLine RX Ltd - ADR
US$ २.४१
-०.८२%
(-०.०२०) 1D
सेप्टेम्बर २९, ०९:३०:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BLRX...
Open
US$ २.४१
High
US$ २.४१
Low
US$ २.४१
Mkt. cap
१.२६ करोड
Avg. vol.
२२.५८ हजार
Volume
१.९२ हजार
52-wk high
US$ ४.५६
52-wk low
US$ २.१५
EPS
-US$ ०.४९
Beta
१.५६
Shares outstanding
४९.७८ लाख
No. of employees
२२
Open
US$ २.४१
High
US$ २.४१
Low
US$ २.४१
Mkt. cap
१.२६ करोड
Avg. vol.
२२.५८ हजार
Volume
१.९२ हजार
52-wk high
US$ ४.५६
52-wk low
US$ २.१५
EPS
-US$ ०.४९
Beta
१.५६
Shares outstanding
४९.७८ लाख
No. of employees
२२
Profile
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
About BioLine RX Ltd - ADR
CEOPhilip A. Serlin
Employees२२
Founded२००३
Headquarters-
Sector-
Analyst ratings
Based on 1 analyst giving stock ratings to BLRX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for BLRX in the last 3 months
Highest
Current US$ २.४१
US$ २६.०० (+९७८.८४%)
Average
US$ २६.०० (+९७८.८४%)
Lowest
US$ २६.०० (+९७८.८४%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Buy
Maintained
US$ २६.००
+९७८.८%
08/31/2026
Justin Walsh
JonesTrading
Buy
Reiterated
US$ १२.००
+३९७.९%
06/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
४.२७ लाख
१.९४ लाख
४.७७ लाख
२.९४ लाख
Cost of goods sold
८४.०० हजार
४०.०० हजार
९५.०० हजार
५९.०० हजार
Cost of revenue
८४.०० हजार
४०.०० हजार
९५.०० हजार
५९.०० हजार
Research and development expenses
१७.१९ लाख
२४.२५ लाख
२५.२८ लाख
२९.४३ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
८.३१ लाख
११.१५ लाख
८.५८ लाख
८.६५ लाख
Operating expense
२५.५० लाख
३५.४० लाख
३३.८६ लाख
३८.०८ लाख
Total operating expenses
२६.३४ लाख
३५.८० लाख
३४.८१ लाख
३८.६७ लाख
Operating income
-२२.०७ लाख
-३३.८६ लाख
-३०.०४ लाख
-३५.७३ लाख
Other non operating income
११.५७ लाख
१०.९८ लाख
४.५८ लाख
-६.९० लाख
EBT including unusual items
-९.७७ लाख
-२२.३६ लाख
-२५.८८ लाख
-४३.३९ लाख
EBT excluding unusual items
-९.७७ लाख
-२२.३६ लाख
-२५.८८ लाख
-४३.३९ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-९.७७ लाख
-१३.८५ लाख
-१६.०१ लाख
-३०.२६ लाख
Net profit margin
-२२८.८१%
-७१३.९२%
-३३५.६४%
-१,०२९.२५%
Earnings per share
-
-
-
-
Interest and investment income
३.७७ लाख
-
२.०८ लाख
१.३२ लाख
Interest expense
-३.०४ लाख
-२.८८ लाख
-२.५० लाख
-२.०८ लाख
Net interest expenses
७३.०० हजार
-२.८८ लाख
-४२.०० हजार
-७६.०० हजार
Depreciation and amortization charges
-
-
-
-
EBITDA
-२०.८८ लाख
-३३.२९ लाख
-२९.१६ लाख
-३४.९५ लाख
Gain or loss from assets sale
-
२५.०० हजार
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू